Akeso (STU:4RY) Accumulated Depreciation : €-59.4 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Akeso Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Akeso's quarterly accumulated depreciation increased from Dec. 2023 (€-36.7 Mil) to Jun. 2024 (€-46.5 Mil) and increased from Jun. 2024 (€-46.5 Mil) to Dec. 2024 (€-59.4 Mil).

Akeso's annual accumulated depreciation increased from Dec. 2022 (€-21.9 Mil) to Dec. 2023 (€-36.7 Mil) and increased from Dec. 2023 (€-36.7 Mil) to Dec. 2024 (€-59.4 Mil).

Akeso Accumulated Depreciation Historical Data

The historical data trend for Akeso's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Accumulated Depreciation Chart

Akeso Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-6.22

-11.93

-21.91

-36.72

-59.40

Akeso Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial								-21.91	-	-36.72	-46.48	-59.40

Akeso Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Akeso Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Akeso's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (STU:4RY) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

AKESF:USA 09926:Hong Kong

Address

6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437

Website

https://www.akesobio.com

Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.

Akeso Headlines

No Headlines